Table 3 Comparison between patients who developed complications to those with no complications post-TAVI
From: Aortic valve calcium score in prediction of post-TAVI complications in an Egyptian cohort
|  | Patients with complication (n = 14) | Patients with no complications (n = 16) | P value |
|---|---|---|---|
| Â | Median (range) | Median (range) | Â |
Age | 72 (56–86) | 81 (60–87) | 0.10 |
Aortic valve calcium score | 4765 (3504–7448) | 1666 (413–3460) | < 0.001 |
Annulus long axis | 28.6 (19–36) | 26.1 (21–31) | 0.03 |
Annulus short axis | 23.5 (20–33) | 22 (18–25) | 0.10 |
Annulus area | 496 (340–655) | 451 (342–588) | 0.23 |
Annulus perimeter | 82.2 (67–90.4) | 76 (66–86) | 0.07 |
ST junction short axis | 28 (20.1–34) | 27.5 (18.4–32) | 0.54 |
ST junction long axis | 29 (25–34) | 28.2 (22.5–33) | 0.58 |
Ascending aorta short axis | 34.5 (28–37) | 338 (26–39) | 0.5 |
Ascending aorta long axis | 35.6 (29–38) | 35.1 (29–40) | 0.4 |
Distance bet. annulus and right ostium in mm | 16.5 (12–20) | 15 (8–20) | 0.28 |
Distance bet. annulus and left ostium in mm | 13 (9–19) | 13.6 (6.3–17) | 0.72 |
| Â | Number (%) | Number (%) | Â |
|---|---|---|---|
Gender, male | 12 (85.7%) | 10 (62.5%) | 0.22 |
Smoking | 8 (57.1%) | 9 (56.2%) | 0.96 |
Diabetes mellitus | 9 (64.3%) | 6 (37.5%) | 0.27 |
Hypertension | 7 (50%) | 12 (75%) | 0.15 |
Hyperlipidemia | 7 (50%) | 7 (43.8%) | 0.73 |
Left ventricular hypertrophy | 7 (50%) | 9 (56.2%) | 0.94 |
Left ventricular septal bulge | 5 (35%) | 5 (31.2%) | 0.093 |